[Hub]/) : Traits : Weight : ← →

chr12:55,601,472-57,125,879

Best TWAS P=1.06e-13 · Best GWAS P=1.27e-12 conditioned to NaN

Associated models

#	Study	Tissue	Gene	h2	eQTL R2	model	# weights	model R2	model R2 P	eQTL GWAS Z	TWAS Z	TWAS P	Top SNP corr	PP3	PP4	joint
4	GTEx	Breast Mammary Tissue (Female)	RPS26	0.20	0.11	lasso	3	0.10	6.6e-04	-5.0	-7.4	1.1e-13	0.84	0.01	0.83	TRUE
9	GTEx	Muscle Skeletal	AC034102.1	0.28	0.31	lasso	4	0.31	2.3e-31	-6.0	6.2	4.2e-10	-0.66	0.62	0.38	TRUE
31	The Cancer Genome Atlas	Pancreatic Adenocarcinoma	ESYT1	0.16	0.02	blup	33	0.05	5.5e-03	2.7	-5.9	3.8e-09	0.30	0.01	0.66	TRUE
29	The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	RPS26	0.22	0.31	lasso	3	0.31	1.6e-35	-5.3	-5.6	1.6e-08	0.65	0.95	0.05	TRUE
13	GTEx	Thyroid	SUOX	0.37	0.40	lasso	7	0.38	5.4e-31	-5.0	5.2	2.0e-07	-0.70	1.00	0.00	TRUE
3	GTEx	Breast Mammary Tissue	RPS26	0.29	0.05	enet	37	0.12	9.4e-07	-5.3	-6.8	9.7e-12	0.63	0.25	0.74	FALSE
10	GTEx	Prostate	SUOX	0.22	0.04	enet	11	0.05	2.3e-02	-5.0	6.4	1.4e-10	-0.67	0.06	0.65	FALSE
8	GTEx	Muscle Skeletal	RAB5B	0.29	0.32	lasso	4	0.33	1.3e-33	-6.0	6.2	4.2e-10	-0.66	0.63	0.37	FALSE
30	The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	RPS26	0.30	0.20	lasso	4	0.24	3.9e-16	-5.3	-5.9	4.9e-09	0.67	0.19	0.81	FALSE
37	The Cancer Genome Atlas	Skin Cutaneous Melanoma	RPS26	0.28	0.15	lasso	2	0.17	3.0e-05	-5.9	-5.8	8.1e-09	0.69	0.02	0.94	FALSE
39	The Cancer Genome Atlas	Testicular Germ Cell Tumors	RPS26	0.46	0.64	lasso	4	0.65	8.5e-30	-5.3	-5.7	1.2e-08	0.64	0.41	0.59	FALSE
19	The Cancer Genome Atlas	Colon Adenocarcinoma	RPS26	0.43	0.48	lasso	4	0.47	1.8e-30	-5.3	-5.7	1.4e-08	0.65	0.87	0.13	FALSE
28	The Cancer Genome Atlas	Lung Adenocarcinoma	RPS26	0.26	0.45	enet	9	0.47	3.6e-61	-5.3	-5.6	1.9e-08	0.66	0.95	0.05	FALSE
17	The Cancer Genome Atlas	Breast Invasive Carcinoma	RPS26	0.30	0.44	enet	10	0.45	5.2e-104	-5.3	-5.6	2.0e-08	0.64	0.95	0.05	FALSE
34	The Cancer Genome Atlas	Prostate Adenocarcinoma	RPS26	0.33	0.52	enet	9	0.54	5.6e-66	-5.3	-5.6	2.2e-08	0.65	0.95	0.05	FALSE
18	The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	RPS26	0.23	0.40	lasso	2	0.39	1.5e-20	-5.3	-5.6	2.8e-08	0.64	0.66	0.34	FALSE
38	The Cancer Genome Atlas	Stomach Adenocarcinoma	RPS26	0.19	0.32	lasso	5	0.34	2.0e-25	-5.4	-5.5	3.1e-08	0.63	0.94	0.06	FALSE
20	The Cancer Genome Atlas	Esophageal Carcinoma	RPS26	0.19	0.13	lasso	5	0.11	2.4e-04	-5.3	-5.5	3.4e-08	0.65	0.02	0.94	FALSE
25	The Cancer Genome Atlas	Brain Lower Grade Glioma	RPS26	0.31	0.53	enet	8	0.55	1.7e-74	-5.3	-5.5	4.0e-08	0.65	0.95	0.05	FALSE
12	GTEx	Testis	SUOX	0.27	0.18	lasso	14	0.18	1.4e-08	-5.0	5.5	4.2e-08	-0.67	0.38	0.61	FALSE
23	The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	RPS26	0.27	0.38	enet	8	0.40	5.0e-24	-5.3	-5.5	4.9e-08	0.66	0.95	0.05	FALSE
36	The Cancer Genome Atlas	Soft Tissue Sarcoma	RPS26	0.23	0.31	lasso	3	0.30	2.4e-18	-5.3	-5.4	5.3e-08	0.64	0.83	0.17	FALSE
6	GTEx	Esophagus Gastroesophageal Junction	WIBG	0.16	0.02	lasso	5	0.04	1.9e-02	1.5	5.4	5.5e-08	-0.35	0.03	0.39	FALSE
21	The Cancer Genome Atlas	Glioblastoma Multiforme	RPS26	0.41	0.38	enet	9	0.39	7.9e-13	-5.4	-5.4	5.9e-08	0.63	0.45	0.55	FALSE
16	The Cancer Genome Atlas	Bladder Urothelial Carcinoma	RPS26	0.14	0.22	lasso	2	0.23	4.8e-19	-5.4	-5.4	6.8e-08	0.62	0.79	0.21	FALSE
22	The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	RPS26	0.17	0.29	lasso	4	0.29	6.2e-33	-5.4	-5.4	6.9e-08	0.63	0.94	0.06	FALSE
24	The Cancer Genome Atlas	Brain Lower Grade Glioma	ERBB3	0.07	0.02	blup	29	0.05	2.1e-06	-6.5	-5.4	7.0e-08	0.39	0.00	1.00	FALSE
15	METSIM	Adipose	RPS26	0.30	0.40	lasso	5	0.41	7.2e-66	-5.4	-5.4	7.6e-08	0.62	0.99	0.01	FALSE
27	The Cancer Genome Atlas	Lung Adenocarcinoma	RAB5B	0.03	0.02	enet	7	0.02	4.3e-03	-6.0	-5.4	8.4e-08	0.57	0.02	0.29	FALSE
14	METSIM	Adipose	IKZF4	0.04	0.04	enet	3	0.04	1.0e-06	-5.3	-5.4	8.5e-08	0.61	0.97	0.02	FALSE
5	GTEx	Esophagus Gastroesophageal Junction	SUOX	0.20	0.16	lasso	5	0.19	2.7e-07	-5.0	5.3	1.0e-07	-0.66	0.27	0.70	FALSE
1	CommonMind	Brain Pre-frontal Cortex	RPS26	0.48	0.62	lasso	5	0.63	5.9e-99	-5.3	-5.3	1.1e-07	0.64	0.99	0.01	FALSE
26	The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	RPS26	0.18	0.31	lasso	2	0.29	3.9e-14	-5.3	-5.3	1.2e-07	0.63	0.94	0.06	FALSE
40	The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	RPS26	0.17	0.19	lasso	4	0.18	1.3e-05	-5.3	-5.3	1.2e-07	0.67	0.07	0.90	FALSE
35	The Cancer Genome Atlas	Rectum Adenocarcinoma	RPS26	0.24	0.18	lasso	2	0.20	1.9e-05	-5.3	-5.3	1.4e-07	0.66	0.06	0.45	FALSE
2	GTEx	Artery Tibial	RPS26	0.07	0.02	enet	5	0.01	3.5e-02	-5.3	-5.2	1.8e-07	0.65	0.16	0.43	FALSE
11	GTEx	Skin Sun Exposed Lower leg	SUOX	0.23	0.30	lasso	3	0.29	1.9e-24	-5.0	5.2	1.9e-07	-0.68	1.00	0.00	FALSE
32	The Cancer Genome Atlas	Pancreatic Adenocarcinoma	RPS26	0.36	0.44	lasso	7	0.42	2.4e-19	-5.4	-5.2	2.0e-07	0.64	0.96	0.04	FALSE
7	GTEx	Heart Atrial Appendage	SUOX	0.09	0.10	enet	8	0.09	1.1e-04	-5.3	5.2	2.2e-07	-0.68	0.10	0.73	FALSE
33	The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	RPS26	0.47	0.43	lasso	2	0.44	3.2e-19	-5.0	-5.2	2.4e-07	0.67	0.97	0.03	FALSE